Vice President of Clinical
(m/f/d)
Permanent employment with our customer Basel Land Start date: asap Reference number: 873408/1
Diesen Job teilen oder drucken
Responsibilities
1. Take full ownership of European clinical development strategy, including development pathways, trial design optimization and proactive risk management
2. Provide end-to-end medical and clinical leadership across the entire lifecycle of European clinical programs, ensuring scientific rigor, quality and compliance
3. Lead and manage direct interactions with EMA, Swissmedic and other European regulatory authorities, including oversight of clinical registration dossiers and regulatory submissions
4. Build and maintain strong partnerships with investigators, research sites, CROs/CSOs, and external experts across Europe
5. Act as a key integrator across functions and regions, resolving complex cross-organizational topics between Europe and global stakeholders
6. Monitor and steer timelines, quality and budgets of European clinical projects, adjusting strategies in response to regulatory or market developments
7. Build, lead and develop a high-performing European clinical organization
Profile
8. MD or PhD in pharmaceutical sciences or a related field; EU or Swiss medical license is a strong advantage
9. Solid experience in pharmaceutical companies or CROs, including significant leadership responsibility in European clinical development
10. Proven track record of leading innovative drug programs through EMA registration and approval, up to market launch
11. Deep expertise in EMA regulatory processes, requirements and guidelines, with the ability to independently lead regulator interactions
12. Strong experience operating in complex international matrix organizations
13. Excellent leadership, stakeholder management, and decision-making skills
14. Fluent English and Chinese (written and spoken) are required
Benefits
15. Executive-level impact in shaping a company’s long-term European clinical and regulatory presence
16. Direct reporting line to the Swiss Company CEO
17. Rare opportunity to build something from the ground up in Europe with strong global backing